fluocinolone


Also found in: Medical, Financial, Encyclopedia, Wikipedia.
Related to fluocinolone: Fluocinolone acetonide
Translations

fluocinolone

n fluocinolona
References in periodicals archive ?
01% fluocinolone acetonide (group A), and 2% kojic acid + octinoxate + allantoin (group B) in treatment of melasma.
Each ILUVIEN implant is designed to release submicrogram levels of fluocinolone acetonide (FAc), a corticosteroid, for 36 months.
Making the recommendation, the NICE Appraisal Committee confirmed that Iluvien, which is also known as fluocinolone, is "clinically effective in the treatment of vision impairment associated with chronic DME.
They discuss conjunctival symblepharon therapy; the management of uveitic glaucoma; corneal procedures; cataract extraction and intraocular lens placement; various types of biopsies; therapeutic vitreoretinal surgery for non-infectious intermediate, posterior, and panuveitis; epiretinal membrane removal; fluocinolone acetonide sustained drug delivery; dexamethasone biodegradable intravitreal implants; and biopsy analysis.
Anmeal Pharmaceuticals LLC has announced the launch of its new fluocinolone acetonide 0.
Food and Drug Administration (FDA) for Iluvien(R), (flucocinolone acetonide intravitreal insert), its investigational, sustained drug delivery system releasing sub- microgram levels of fluocinolone acetonide for the treatment of diabetic macular edema (DME).
The triple therapy group applied fluocinolone acetonide 0.
Amneal Pharmaceuticals, LLC is pleased to announce its new Fluocinolone Acetonide 0.
Each ILUVIEN implant with its continuous microdosing is designed to release submicrogram levels of fluocinolone acetonide, a corticosteroid, for 36 months, enabling the physician to treat the disease consistently every day.
Injected into the patient's eye, it delivers sustained sub-microgram levels of fluocinolone acetonide.
The NDA seeks approval to market ILUVIEN (fluocinolone acetonide intravitreal insert), an investigational, sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for the treatment of DME.
The companies added each ILUVIEN implant is designed to release submicrogram levels of fluocinolone acetonide, a corticosteroid, for 36 months.